http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0617664-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-141 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-248 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2006-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dc964426a237f94c79a08737c7ebfbc |
| publicationDate | 2021-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI0617664-B1 |
| titleOfInvention | USE OF AN ANTIBODY THAT RECOGNIZES IL-6 FOR THE PRODUCTION OF A PHARMACEUTICAL COMPOSITION TO TREAT MYOCARDIAL INFARCTION OR SUPPRESS LEFT VENTRICULAR REMODELING AFTER MYOCARDIAL INFARCTION |
| abstract | AGENT TO TREAT MYOCARDIAL INFARCTION AND TO SUPPRESS LEFT VENTRICULAR REMODELING AFTER MYOCARDIAL INFARCTION AND USE OF THE IL-6 INHIBITOR. The present invention relates to the effects of anti-IL-6 receptor antibodies in improving the condition of infarcted areas in myocardial infarction, and in suppressing left ventricular remodeling after myocardial infarction. As a result, administration of anti-IL-6 receptor antibodies significantly suppressed increased MPO activity in the infarcted area and suppressed myocardial MCP-1 expression in both the infarcted and non-infarcted areas. In addition, echocardiographic and histological examinations revealed that cardiac hypertrophy is also suppressed. |
| priorityDate | 2005-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 570.